ClinXus adds new members

March 3, 2009
Print
Text Size:
A A

ClinXus, a nonprofit research alliance that does early-stage clinical trials, has taken on the Cancer & Hematology Centers of Western Michigan and Innovative Analytics as new members.

Cancer & Hematology Centers of Western Michigan is the largest private oncology and hematology medical practice in Michigan. CHCWM will help ClinXus conduct research and clinical trials in the field of oncology, giving ClinXus the potential to move into early-stage cancer research, according to ClinXus executive director and chief medical officer William Baer.

Innovative Analytics is a data management firm that does exploratory studies and clinical drug/device development programs with standard and innovative data management, statistical, and medical writing services. With Innovative Analytics onboard, ClinXus can now provide clinical trial protocol development and analysis of the data collected during research, Bear indicated.

 “We are pleased to welcome these two new companies into our collaboration,” Baer commented. “With their help, we are building world-class research capabilities that, when combined with our alliance of health care providers and researchers, leverages the strength of all of West Michigan as a life sciences corridor.”

ClinXus operates out of the West Michigan Science & Technology Initiative’s Venture Center at Grand Valley State University’s Cook-DeVos Center for Health Sciences.

According to WMSTI Executive Director Linda Chamberlain, Ph.D., ClinXus stands out in the medical industry because it is a collaboration of the community’s clinical trial resources.

“Since 2006, they have worked with the Initiative and other community organizations to achieve the kind of success and industry respect that help to put West Michigan on the map as a life science hub,” Chamberlain said. “This year, we look forward to their continued growth and strengthening of the life sciences community in Michigan.” 

ClinXus expects to add members and expand its capabilities further this year.

Editor's Picks

Comments powered by Disqus